Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers report early success using saliva to detect oral cancer

21.12.2004


Scientists funded by the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health, reported today taking a major step forward in using saliva to detect oral cancer. As published in the current issue of Clinical Cancer Research, the scientists found they could measure for elevated levels of four distinct cancer-associated molecules in saliva and distinguish with 91 percent accuracy between healthy people and those diagnosed with oral squamous cell carcinoma.



This so-called "proof-of-principle" study marks the first report in the scientific literature that distinct patterns of "messenger RNA" not only are measurable in saliva but can indicate a developing tumor. Messenger RNA (mRNA) is the molecular intermediate between gene and protein, serving as a chemical record that an individual gene has been expressed.

According to David Wong, D.M.D., D.M.Sc., a scientist at the University of California at Los Angeles (UCLA) School of Dentistry and senior author on the paper, it may be possible with further refinement of the test, possibly by including additional cancer-linked mRNAs, to attain the necessary 99 to 100 percent accuracy of commercial diagnostic tests for oral squamous cell carcinoma, the sixth most common cancer in the United States. Wong noted that currently no biochemical or genetic diagnostic tests are commercially available for oral cancer.


He also noted that the RNA patterns in saliva may be informative for other cancers and common diseases. "Saliva is a mirror of our blood," said Wong. "We’re now conducting our initial studies of saliva as a possible diagnostic fluid for other human cancers and system diseases, and we should have our preliminary data in the Spring."

Wong said he and his colleagues never intended to study mRNA patterns in saliva. They had been searching exclusively in the mouth’s soft tissues, or mucosa, for proteins that might be associated with oral cancer, when Maie St. John, M.D., Ph.D., a head-and-neck surgery/otolaryngology resident at UCLA, who was then on a training rotation in Wong’s lab, posed a simple question: If proteins associated with cancer are present in the oral mucosa, can they also pass from tissue into the saliva?

While looking for cancer-linked proteins in saliva, St. John happened to notice mRNA from the gene encoding one of her proteins of interest. This chance discovery raised two intriguing possibilities that would alter the course of research in Wong’s lab: Does saliva contain a wide range of different mRNAs that have value in diagnosing disease? If correct, are there different collective patterns of mRNA in the saliva of a healthy person compared with someone who has a developing cancer?

St. John said pursuing this line of research was potentially important because previous studies had established that mRNA can be as informative of health and disease as changes in protein or DNA. In addition, mRNA has the key advantage over these more traditional analytes in that it can be readily extracted in bulk from a tissue or bodily fluid and processed much faster for a comprehensive picture of which mRNAs are present in a given tissue or bodily fluid and at which levels. "What really interested us was the idea that mRNA analyses could be performed in a bodily fluid as easily obtained as saliva," said St. John. "If correct, a salivary test in theory would be quick, painless, and most likely less expensive than current diagnostic tests."

But would it be as informative as testing blood? Before they could answer this question, Wong and colleagues first had to define all of the individual mRNAs naturally present in saliva. As published this year in the Journal of Dental Research, they found people have about 3,000 chemically distinct mRNAs in their saliva at any one time. Of this total, a "core signature" of about 280 mRNAs are generally present in the saliva of healthy people.

With these baseline data as their scientific anchor, the researchers could begin to test whether saliva contains distinct mRNA patterns. "We obtained saliva and blood from 32 people who had been recently diagnosed with oral squamous cell carcinoma but not treated," said Yang Li, D.D.S., Ph.D., lead author on the study and a researcher in Wong’s laboratory. "Because salivary diagnostics with RNA had yet to be tried, we referenced all of our data through blood. That is, whatever we found in saliva, we looked to see if it matched our data in blood."

As presented in their current Clinical Cancer Research paper, the scientists extracted the mRNA from the saliva of the cancer patients and soon discovered 1,679 genes were expressed at significantly different levels in the cancer patients compared to healthy individuals. Upon further analysis, they noticed seven mRNAs in particular that were present at a 3.5-fold higher level in the cancer patients. Interestingly, among them was the mRNA for the gene IL-8, whose protein St. John had originally searched for in saliva.

The researchers then whittled down their list of signature mRNAs to four, based on statistical models that indicated the synchronized rise in expression of these four molecules increased the probability that the saliva belonged to a cancer patient. These four mRNAs are from the following genes: Interleukin 1-beta (IL1B), Ornithine decarboxylase antizyme 1 (OAZ1), spermidine/spermine N1-acetyl transferase (SAT), and interleukin 8 (IL-8).

To put this idea to the test, they screened the saliva again to see how often they could correctly identify the samples from the cancer patients. In all instances, they had no foreknowledge of whether a healthy person or a cancer patient provided the saliva sample.

Wong said the group could identify the saliva from cancer patients in nine out of 10 samples. What’s more, he said the sensitivity and specificity of their saliva tests were as good or better than their reference work in blood. "This was primarily an exploratory study to validate our initial finding of a unique molecular signature of mRNAs in people with oral squamous cell carcinoma," said Wong. "We will follow up with a larger cohort of about 200 patients in the near future, and this study will hopefully allow us to distinguish in saliva between the various stages of the cancer and ultimately push our accuracy up to as close to 100 percent as possible."

He also noted that these initial results serve to highlight the potential clinical value of saliva as a diagnostic biofluid. "Many have thought of saliva as very difficult to work with in the laboratory, in part because the molecular information contained within it is highly degradable," said Wong. "The truth is oral health researchers have worked on saliva for decades, and they have established defined ways to work with fluids that are consistent, reproducible, and which keep these molecules in a stable state. We have a marvelous way to completely stop the degradation of mRNA in saliva, and it allowed us to gather these data."

Bob Kuska | EurekAlert!
Further information:
http://www.nidcr.nih.gov

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>